168 related articles for article (PubMed ID: 33373033)
1. Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer.
Rico SD; Höflmayer D; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Möller-Koop C; Perez D; Izbicki JR; Neipp M; Mofid H; Lárusson H; Daniels T; Isbert C; Coerper S; Ditterich D; Rupprecht H; Goetz A; Fraune C; Möller K; Menz A; Bernreuther C; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Lebok P; Burandt E; Krech T; Marx AH
Med Mol Morphol; 2021 Jun; 54(2):156-165. PubMed ID: 33373033
[TBL] [Abstract][Full Text] [Related]
2. MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancer.
Rico SD; Schmalfeldt B; Müller V; Wölber L; Witzel I; Paluchowski P; von Leffern I; Heilenkötter U; Jacobsen F; Bernreuther C; Clauditz T; Simon R; Steurer S; Burandt E; Marx AH; Krech T
Pathol Res Pract; 2021 Aug; 224():153533. PubMed ID: 34171599
[TBL] [Abstract][Full Text] [Related]
3. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
[TBL] [Abstract][Full Text] [Related]
4. [Expression of secreted frizzled-related protein 4 in DNA mismatch repair-deficient and mismatch repair-proficient colorectal cancers].
Chen K; Liang H; Peng J; Zheng Y
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1300-1305. PubMed ID: 30514676
[TBL] [Abstract][Full Text] [Related]
5. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers.
Hale VL; Jeraldo P; Chen J; Mundy M; Yao J; Priya S; Keeney G; Lyke K; Ridlon J; White BA; French AJ; Thibodeau SN; Diener C; Resendis-Antonio O; Gransee J; Dutta T; Petterson XM; Sung J; Blekhman R; Boardman L; Larson D; Nelson H; Chia N
Genome Med; 2018 Oct; 10(1):78. PubMed ID: 30376889
[TBL] [Abstract][Full Text] [Related]
6. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
[TBL] [Abstract][Full Text] [Related]
7. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
[TBL] [Abstract][Full Text] [Related]
8. MUC5AC hypomethylation is a predictor of microsatellite instability independently of clinical factors associated with colorectal cancer.
Renaud F; Vincent A; Mariette C; Crépin M; Stechly L; Truant S; Copin MC; Porchet N; Leteurtre E; Van Seuningen I; Buisine MP
Int J Cancer; 2015 Jun; 136(12):2811-21. PubMed ID: 25403854
[TBL] [Abstract][Full Text] [Related]
9. Mismatch Repair Status Correlates with Survival in Young Adults with Metastatic Colorectal Cancer.
van der Heide DM; Turaga KK; Chan CHF; Sherman SK
J Surg Res; 2021 Oct; 266():104-112. PubMed ID: 33989889
[TBL] [Abstract][Full Text] [Related]
10. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers.
Sønderstrup IM; Nygård SB; Poulsen TS; Linnemann D; Stenvang J; Nielsen HJ; Bartek J; Brünner N; Nørgaard P; Riis L
Mol Oncol; 2015 Jun; 9(6):1207-17. PubMed ID: 25777966
[TBL] [Abstract][Full Text] [Related]
12. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.
Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics and Outcomes of Treatment in Patients with Stage IV Colorectal Cancer with Mismatch Repair Deficiency].
Ishibashi K; Chika N; Suzuki O; Ito T; Amano K; Kumamoto K; Fukuchi M; Kumagai Y; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1711-1714. PubMed ID: 28133107
[TBL] [Abstract][Full Text] [Related]
14. [Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer].
Tang XJ; Yang MY; Zhu LZ; Xu D; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1088-1093. PubMed ID: 34695900
[No Abstract] [Full Text] [Related]
15. [Correlation between mismatch repair proteins status and clinicopathological characteristics in sporadic colorectal cancer patients].
Xiao ZT; Zhang RX; Zhao Y; Peng JH; Lu SX; Zhang HZ; Ding PR; Wu XJ; Lu ZH; Li LR; Wan DS; Pan ZZ; Chen G
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(16):1248-1251. PubMed ID: 28441855
[No Abstract] [Full Text] [Related]
16. Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions.
Park ET; Gum JR; Kakar S; Kwon SW; Deng G; Kim YS
Int J Cancer; 2008 Mar; 122(6):1253-60. PubMed ID: 18027866
[TBL] [Abstract][Full Text] [Related]
17. Different surgical outcome and follow-up status between dMMR and pMMR colorectal cancer patients who fulfilled with Amsterdam-II criteria.
Sun CY; Chiang JM; Chen TC; Hung HY; You JF
World J Surg Oncol; 2020 Aug; 18(1):195. PubMed ID: 32767993
[TBL] [Abstract][Full Text] [Related]
18. LDH-A negatively regulates dMMR in colorectal cancer.
Zhang Y; Li J; Wang B; Chen T; Chen Y; Ma W
Cancer Sci; 2021 Aug; 112(8):3050-3063. PubMed ID: 34110068
[TBL] [Abstract][Full Text] [Related]
19. Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma.
Dwertmann Rico S; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Perez D; Izbicki JR; Neipp M; Mofid H; Daniels T; Isbert C; Fraune C; Möller K; Menz A; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Burandt E; Marx A; Krech T
Int J Immunopathol Pharmacol; 2022; 36():3946320221106504. PubMed ID: 35764407
[No Abstract] [Full Text] [Related]
20. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM
Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
